Sighoko Dominique, Murphy Anne Marie, Irizarry Bethliz, Rauscher Garth, Ferrans Carol, Ansell David
Metropolitan Chicago Breast Cancer Task Force, 300 S. Ashland, Suite 202, Chicago, IL, 60607, USA.
Department of Health Systems Management, Rush University Medical Center, 1700 W. Van Buren Street, Chicago, IL, 60612, USA.
Cancer Causes Control. 2017 Jun;28(6):563-568. doi: 10.1007/s10552-017-0878-y. Epub 2017 Mar 8.
Assess progress made to reduce racial disparity in breast cancer mortality in Chicago compared to nine other cities with largest African American populations and the US.
The Non-Hispanic Black (NHB) and Non-Hispanic White (NHW) female breast cancer mortality rates and rate ratios (RR) (disparity) were compared between 1999 and 2005 and 2006 and 2013.
Between the two periods, the NHB breast cancer mortality rate in Chicago decreased by 13.9% (95% CI [-13.81, -13.92] compared to 7.7% (95% CI [-7.52, -7.83]) for NHW. A drop of 20% in the disparity was observed, from 51% (RR: 1.51, 95% CI [-7.52, -7.83]) to 41% (RR: 1.41, 95% CI [1.30, 1.52]). Whereas from 1999 to 2005 Chicago's disparity was above that of the U.S., from 2006 to 2013, it is now slightly lower. For the remaining nine cities and the US, the mortality disparity either grew or remained the same.
Chicago's improvement in NHB breast cancer mortality and disparity reduction occurred in the context of city-wide comprehensive public health initiatives and shows promise as a model for other cities with high health outcome disparities.
评估与其他九个非裔美国人人口最多的城市以及美国相比,芝加哥在降低乳腺癌死亡率方面取得的进展。
比较了1999年至2005年以及2006年至2013年期间非西班牙裔黑人(NHB)和非西班牙裔白人(NHW)的女性乳腺癌死亡率及率比(RR)(差距)。
在这两个时期之间,芝加哥的NHB乳腺癌死亡率下降了13.9%(95%置信区间[-13.81, -13.92]),而NHW的死亡率下降了7.7%(95%置信区间[-7.52, -7.83])。差距下降了20%,从51%(RR:1.51,95%置信区间[-7.52, -7.83])降至41%(RR:1.41,95%置信区间[1.30, 1.52])。1999年至2005年期间,芝加哥的差距高于美国,但2006年至2013年,差距略低于美国。对于其余九个城市和美国而言,死亡率差距要么扩大,要么保持不变。
芝加哥在NHB乳腺癌死亡率方面的改善以及差距的缩小是在全市范围的综合公共卫生举措背景下实现的,有望成为其他健康结果差距较大城市的典范。